Carcinoma in situ of skin of unspecified part of face is a non-invasive form of skin cancer characterized by abnormal growth of skin cells. It is often caused by prolonged sun exposure or other environmental factors. Accurate coding with ICD-10 Code D04.30 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can track incidence and treatment outcomes effectively.
ICD-10 Code D04.30 represents carcinoma in situ of skin located on an unspecified part of the face. This condition is a precursor to invasive skin cancer and requires careful monitoring and treatment. The code should be used in clinical documentation when a patient is diagnosed with this specific type of skin cancer, ensuring accurate billing and continuity of care.
Carcinoma in situ of skin of unspecified part of face is a localized skin cancer that has not invaded deeper tissues. It is primarily caused by UV radiation exposure and can progress to invasive cancer if left untreated. Prompt medical attention is necessary to prevent complications and ensure effective treatment.
ICD-10 Code D04.30 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of skin of unspecified part of face. It plays a crucial role in capturing patient symptoms, assessment findings, and treatment plans, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D04.30 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Treatment for carcinoma in situ of skin of unspecified part of face is essential to prevent progression to invasive cancer. Options include surgical excision, cryotherapy, or topical chemotherapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.30 is crucial for accurate billing in hospital, ER, or outpatient settings for patients diagnosed with carcinoma in situ.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm. |
| 11100 | Biopsy of skin, excisional, including closure. |
| 17000 | Destruction of skin lesions, first lesion. |
Common Questions About Using ICD-10 Code D04.30 for Carcinoma in situ of skin of unspecified part of face
What are the treatment options for carcinoma in situ?
Treatment options for carcinoma in situ of skin include surgical excision, cryotherapy, and topical chemotherapy. The choice of treatment depends on the lesion's size, location, and patient factors.
How is carcinoma in situ diagnosed?
Carcinoma in situ is diagnosed through a skin biopsy, where a sample of the lesion is examined microscopically for atypical cells. Clinical examination may also provide diagnostic clues.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a form of skin cancer, although it is non-invasive. It has the potential to progress to invasive cancer if not treated.
What is the prognosis for carcinoma in situ?
The prognosis for carcinoma in situ is generally excellent with appropriate treatment. Early detection and intervention significantly reduce the risk of progression to invasive cancer.
Clinical Notes
SOAP notes
DAP notes
AI medical notes